Effects of Leucine-Enriched Whey Protein Supplementation on Physical Function in Post-Hospitalized Older Adults Participating in 12-Weeks of Resistance Training Program: A Randomized Controlled Trial - PubMed (original) (raw)

Randomized Controlled Trial

. 2019 Oct 1;11(10):2337.

doi: 10.3390/nu11102337.

Affiliations

Randomized Controlled Trial

Effects of Leucine-Enriched Whey Protein Supplementation on Physical Function in Post-Hospitalized Older Adults Participating in 12-Weeks of Resistance Training Program: A Randomized Controlled Trial

Maria Amasene et al. Nutrients. 2019.

Abstract

Age-related strength and muscle mass loss is further increased after acute periods of inactivity. To avoid this, resistance training has been proposed as an effective countermeasure, but the additional effect of a protein supplement is not so clear. The aim of this study was to examine the effect of a whey protein supplement enriched with leucine after resistance training on muscle mass and strength gains in a post-hospitalized elderly population. A total of 28 participants were included and allocated to either protein supplementation or placebo supplementation following resistance training for 12 weeks (2 days/week). Physical function (lower and upper body strength, aerobic capacity and the Short Physical Performance Battery (SPPB) test), mini nutritional assessment (MNA) and body composition (Dual X-ray Absorptiometry) were assessed at baseline and after 12 weeks of resistance training. Both groups showed improvements in physical function after the intervention (p < 0.01), but there were no further effects for the protein group (_p_ > 0.05). Muscle mass did not improve after resistance training in either group (p > 0.05). In conclusion, 12 weeks of resistance training are enough to improve physical function in a post-hospitalized elderly population with no further benefits for the protein-supplemented group.

Keywords: aging; elderly; leucine; muscle mass; protein supplementation; resistance training; strength; whey protein.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The founding sponsors had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, and in the decision to publish the results.

Figures

Figure 1

Figure 1

Flow Diagram of participants.

Similar articles

Cited by

References

    1. Fielding R.A., Vellas B., Evans W.J., Bhasin S., Morley J.E., Newman A.B., Abellan van Kan G., Andrieu S., Bauer J., Breuille D., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 2011;12:249–256. doi: 10.1016/j.jamda.2011.01.003. - DOI - PMC - PubMed
    1. Schaap L.A., van Schoor N.M., Lips P., Visser M. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: The Longitudinal Aging Study Amsterdam. J. Gerontol. 2018;73:1199–1204. doi: 10.1093/gerona/glx245. - DOI - PubMed
    1. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 2002;50:889–896. doi: 10.1046/j.1532-5415.2002.50216.x. - DOI - PubMed
    1. Landi F., Liperoti R., Fusco D., Mastropaolo S., Quattrociocchi D., Proia A., Tosato M., Bernabei R., Onder G. Sarcopenia and mortality among older nursing home residents. J. Am. Med. Dir. Assoc. 2012;13:121–126. doi: 10.1016/j.jamda.2011.07.004. - DOI - PubMed
    1. Mitchell W.K., Williams J., Atherton P., Larvin M., Lund J., Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front. Physiol. 2012;11:260. doi: 10.3389/fphys.2012.00260. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources